Abstract: An apparatus includes a photovoltaic module and a computation module that is coupled to the photovoltaic module and is configured to receive power therefrom, the computation module being configured to communicate an active message to a controller in response to the computation module transitioning to a power on state and configured to receive a task command from the controller in response to communicating the active message to the controller.

Abstract: A plasticized terephthalate-based polyester blend comprising a terephthalate-based polyester (e.g., polyethylene terephthalate, i.e., PET) homogeneously blended with a fatty acid or ester thereof, wherein said fatty acid or ester thereof is present in said polyester blend in an amount of 1-50 wt %. Also described herein is a method for producing a plasticized terephthalate-based polyester blend, the method comprising melt mixing a terephthalate-based polyester with a fatty acid or ester thereof at a temperature in a range of 230-250° C. to produce said polyester blend, wherein said fatty acid or ester thereof is present in said polyester blend in an amount of 1-50 wt % and is homogeneously blended with said terephthalate-based polyester.

Abstract: This invention provides novel indole, indazole, benzimidazole, benzotriazole, indoline, quinolone, isoquinoline, and carbazole selective androgen receptor degrader (SARD) compounds, pharmaceutical compositions and uses thereof in treating hyperproliferations of the prostate including pre-malignancies and benign prostatic hyperplasia, prostate cancer, advanced prostate cancer, castration resistant prostate cancer, other AR-expressing cancers, androgenic alopecia or other hyper androgenic dermal diseases, Kennedy's disease, amyotrophic lateral sclerosis (ALS), abdominal aortic aneurysm (AAA), and uterine fibroids, and to methods for reducing the levels (through degradation) and/or activity (through inhibition) of any androgen receptor including androgen receptor-full length (AR-FL) including pathogenic and/or resistance mutations, AR-splice variants (AR-SV), and pathogenic polyglutamine (polyQ) polymorphisms of AR in a subject.

Abstract: Methods of preparing cast-in-place geopolymer piles using electrical heating wire (130) to provide heat to cure the piles are described. The heating wire (130) can be associated with a reinforcement cage (120) inserted in the pile shaft. Rod-shaped heating units comprising electrical heating wire (130) can be inserted into a pile shaft and can be reusable. Geopolymer piles with high compressive strength can be prepared from mixtures of class F fly ash and aqueous sodium hydroxide by heating the piles with the heating wire to a stable curing temperature for at least about 24 hours.

Abstract: A multi-dimensional holomorphic embedding method for voltage control of an AC power system includes embedding multiple independent symbolic variables representing multiple control elements of the AC power system into AC power flow equations that describe the AC power system, analytically solving voltages for targeted buses of the AC power system in a form of multivariate power series or multivariable Padé approximants about the multiple independent symbolic variables such that coefficients of the multivariate power series or multivariable Padé approximants are obtained non-iteratively, and jointly adjusting the multiple control elements according to the multivariate power series or multivariable Padé approximants to control voltages of the targeted buses.

Abstract: An apparatus and method is described for a supplemental feeder system that provides a spring loaded supplemental feeder mounted on and spaced along a feed line. The spring loaded supplemental feeder acts as control that controls one or more follower supplemental feeders that is attached to control the one or more distally space apart supplemental feeders to dispense feed. The apparatus includes a pair of left and right annular collar clamps spaced apart and a tubular collar coaxial with respect to the left and right annular collar clamps and rotationally attached to the left and right annular collars. An extension tube having an interior extension channel is communicably attached to an interior channel of the tubular collar.

Abstract: Methods and apparatus are disclosed for high-efficiency thermal storage with a fluid-filled “battery” tank positioned within a fluid-filled “reservoir” tank. Fluid loops couple the tanks to a heat pump and a building. The heat pump can charge the battery tank or deliver thermal energy (cold or heat) to a building, using the reservoir tank or ambient air as a thermal energy source. The battery tank can discharge energy to the building jointly with the heat pump or, at periods of peak electricity usage, with the heat pump switched off. Operating modes allow significant savings in electricity usage and mitigate the “duck curve.” Low duty cycle usage of the reservoir enables efficient underground thermal storage with less digging than conventional geothermal technologies. Additional efficiency is achieved with phase change materials installed inside a tank or in a tank wall, providing temperature regulation. Control methods are disclosed.

Abstract: A resistance system is disclosed. The resistance system has a line reel system for deploying a tension line and a power system for drawing in the slack line. The resistance value can be set by a subject using the device by using a resistance controller and indicator located on an outer surface of the system. The system can be self-contained with an internal power supply. The system is particularly useful for swim training or rehabilitation. It can be simply operated by a user without removing the device.

Abstract: The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating cancer and drug-resistant tumors, e.g. melanoma, metastatic melanoma, drug resistant melanoma, prostate cancer and drug resistant prostate cancer.

Abstract: This invention is directed to pyrrole, pyrazole, imidazole, triazole, and morpholine based selective androgen receptor degrader (SARD) compounds including heterocyclic anilide rings and their synthetic precursors, R-isomers, and non-hydroxylated and/or non-chiral propanamides, and pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, triple negative breast cancer, other cancers expressing the androgen receptor, androgenic alopecia or other hyperandrogenic dermal diseases, Kennedy's disease, amyotrophic lateral sclerosis (ALS), abdominal aortic aneurysm (AAA), and uterine fibroids, and to methods for reducing the levels of androgen receptor-full length (AR-FL) including pathogenic or resistance mutations, AR-splice variants (AR-SV), and pathogenic polyglutamine (polyQ) polymorphisms of AR in a subject.

Abstract: Codoped rare earth garnet-type oxide scintillators are described. More particularly, the scintillators include lutetium yttrium aluminum garnet (LuYAG)-type materials that are doped with an activator, such as praseodymium, and codoped with a monovalent cation, such as lithium. Radiation detectors comprising the scintillators, methods of detecting higher energy radiation using the scintillators, and methods of preparing the scintillators and altering scintillator properties are also described.

Abstract: This invention is directed to pyrrole, pyrazole, imidazole, triazole, and morpholine based selective androgen receptor degrader (SARD) compounds including cyclic and heterocyclic anilide rings and their synthetic precursors, and mono-, di-, or multi-substituted N-heterocyclic rings, R-isomers, non-hydroxylated and/or non-chiral propanamides in treating androgen receptor dependent diseases and conditions such as hyperproliferations of the prostate including pre-malignancies and benign prostatic hyperplasia, prostate cancer, advanced prostate cancer, castration resistant prostate cancer, triple negative breast cancer, other cancers expressing the androgen receptor, androgenic alopecia or other hyperandrogenic dermal diseases, Kennedy's disease, amyotrophic lateral sclerosis (ALS), abdominal aortic aneurysm (AAA), and uterine fibroids, and to methods for reducing the levels of androgen receptor-full length (AR-FL) including pathogenic or resistance mutations, AR-splice variants (AR-SV), and pathogenic polyglutam

Abstract: The present invention relates to solid forms of (S)—N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same.

Abstract: The present subject matter relates to orthotic devices, systems, and methods configured to support a lumbar spine. In some embodiments, a lumbar spinal orthosis system includes a torso belt configured to be secured about a torso of a user, a pelvic belt configured to be secured about a pelvis of the user, and a distractive force mechanism connected between the torso belt and the pelvic belt. The distractive force mechanism is configured to generate a force between the torso belt and the pelvic belt acting bi-directionally across a lumbar spine of the user to substantially offload bodyweight of the user passing through the lumbar spine.

Abstract: A method includes performing by a processor: receiving a plurality of synchrophasor measurements of a power system signal associated with a time interval from a phasor measurement unit (PMU), each of the plurality of synchrophasor measurements including a phase angle, frequency value, and a timestamp associated with the synchrophasor measurement, determining a plurality of relative phase angles based on the plurality of phase angles, determining a correlation coefficient between the plurality of relative phase angles and a plurality of corresponding frequency values of the power system signal, and detecting an error in the plurality of timestamps based on the correlation coefficient; estimating the error in the plurality of timestamps based on the plurality of relative phase angles and the plurality of corresponding frequency values.

Abstract: As described below, the present invention features compositions and methods for inhibiting inflammation in connection with an acellular template (e.g., an electrospun template). In one embodiment, the template is impregnated with an agent (e.g., N-?-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide (Cl-amidine)) that inhibits a peptidylarginine deaminase (e.g., PAD4).

Abstract: The disclosure describes techniques for forming nanoparticles including Fe16N2 phase. In some examples, the nanoparticles may be formed by first forming nanoparticles including iron, nitrogen, and at least one of carbon or boron. The carbon or boron may be incorporated into the nanoparticles such that the iron, nitrogen, and at least one of carbon or boron are mixed. Alternatively, the at least one of carbon or boron may be coated on a surface of a nanoparticle including iron and nitrogen. The nano particle including iron, nitrogen, and at least one of carbon or boron then may be annealed to form at least one phase domain including at least one of Fe16N2, Fe16(NB)2, Fe16(NC)2, or Fe16(NCB)2.

Abstract: A solar powered robotic mower power shed and related methods of use are disclosed. One example robotic mower power shed comprises a housing structure containing one or more compartments. The charging station further includes a roof structure equipped with one or more photovoltaic (PV) cell elements, wherein the one or more PV cell elements are configured to generate electrical energy from captured solar energy. The charging station also includes a charge control unit configured to receive electrical energy via a connection to the one or more PV cell elements and to provide the electrical energy to at least a robotic mower device docked in the housing structure.

Abstract: This invention is directed to selective androgen receptor degrader (SARD) compounds including heterocyclic rings and pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, triple negative breast cancer, other cancers expressing the androgen receptor, androgenic alopecia or other hyperandrogenic dermal diseases, Kennedys disease, amyotrophic lateral sclerosis (ALS), abdominal aortic aneurysm (AAA), and uterine fibroids, and to methods for reducing the levels of androgen receptor-full length (AR-FL) including pathogenic or resistance mutations, AR-splice variants (AR-SV), and pathogenic polyglutamine (polyQ) polymorphisms of AR in a subject.